Cancer BiologyScience AdvancesPeer-reviewed
Inclusion of JNK-independent drugs within multi-agent chemotherapy improves response in relapsed high-risk neuroblastoma
Jeremy Z. R. Han, Monica Phimmachanh, Jordan F. Hastings…·David R. Croucher
The paper identifies JNK-independent drugs that, when combined with standard chemotherapy, improve response in relapsed high-risk neuroblastoma by exploiting differential apoptotic network utilization.
DOI 10.1126/sciadv.ady5599